MYB and leukemia: In AML, MYB rearrangements are rare; however, AML cells are often addicted to higher levels of MYB expression than normal hematopoietic progenitor cells, making the leukemia cells more vulnerable to MYB inhibition than their normal counterparts [32,33,34].